Yesterday, Apple unveiled the iPhone 17, iPhone 17 Pro, iPhone 17 Pro Max, and iPhone Air. All of them come with many new features and specs, but one interesting setting wasn't talked about during the ...

Apple had a lot to say about its new phones during the “Awe Dropping” event Tuesday, but there were plenty of little features that couldn’t fit in the keynote. One interesting feature spotted in the ...

The iPhone 17 models include an Accessibility setting to disable pulse width modulation (PWM), according to information found in the iOS 26 release candidate. There will be a toggle located in the ...

You may have noticed an officer standing just behind the President of India at official events, state visits, or ceremonial functions. That officer holds a very important role as an Aide-de-Camp (ADC) ...

7MW4911, a CDH17-targeting ADC, received FDA IND clearance for Phase I/II trials in advanced colorectal and GI tumors, addressing significant unmet needs. The ADC uses Mabwell's IDDC™ platform, ...

CHANDLER, Ariz., June 18, 2025 (GLOBE NEWSWIRE) -- Evolving security and functional safety demands, coupled with the growing complexity of real-time embedded applications, are driving designers to ...

After flexing its antibody-drug conjugate bona fides at last year’s American Society of Clinical Oncology (ASCO) conference, AbbVie is advancing its solid tumor ambitions with a new FDA green light.

Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal ...

ADC Therapeutics has stopped development of lead solid tumor candidate ADCT-601. The biotech axed the AXL-directed antibody-drug conjugate (ADC) after failing to show a favorable benefit-risk profile ...